Drug Search Results

ACOU-085

Alternative Names: ACOU-085, ACOU085, ACOU 085
Latest Update: 2025-04-29
Latest Update Note: News Article

Product Description

Mechanisms of Action: Potassium Channel Agonist

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral,Injection

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Acousia
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for ACOU-085

Countries in Clinic: Germany

Active Clinical Trial Count: 2

Highest Development Phases

Phase 2: Deafness|Hearing Loss|Hearing Loss, Sensorineural|Testicular Cancer

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
Acousia Study 02	P2	Recruiting	Hearing Loss, Sensorineural	2026-06-30
PROHEAR	P2	Recruiting	Testicular Cancer\|Hearing Loss\|Deafness	2025-03-31	12%

Recent News Events

Date	Type	Title
04/29/2025	News Article	Acousia Therapeutics Reaches 50% Patient Enrollment Milestone in Phase 2 PROHEAR Study
08/12/2024	News Article	Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences
02/15/2024	News Article	Hearing loss company Acousia announces first patient enrolled in its Phase 2 PROHEAR-Study
01/09/2024	News Article	Acousia Therapeutics attracts new investor on its path to make hearing loss a treatable disease

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions